Back to Trades
Rubins Kathleen Hallisey
DirectorCIK 0002145689
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Rubins Kathleen Hallisey, Director, has filed 1 SEC report (2026), all concentrated in FibroBiologics, Inc. (FBLG), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jul 16 | FBLG FibroBiologics, Inc. | Rubins Kathleen Hallisey | Director | Other | $0 |
1 filing